Skip to content
CONTACT US
CAREERS
Share
PIPELINE
AlloCAR T PRODUCT PIPELINE
THE ALPHA3 TRIAL
THE RESOLUTION TRIAL
DATABRIEF
EXPANDED ACCESS
SCIENCE
NEXT REVOLUTION IN CELL THERAPY
PLATFORM FOR TOMORROW
ON-DEMAND AVAILABILITY
SCIENTIFIC PUBLICATIONS
ABOUT US
AT A GLANCE
MANAGEMENT TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORS
PARTNERS
CORPORATE RESPONSIBILITY
NEWS CENTER
PRESS RELEASES
EVENTS
PERSPECTIVES
SOCIAL MEDIA
COMMUNITY GUIDELINES
INVESTORS
IR OVERVIEW
NEWS & EVENTS
PRESS RELEASES
EVENTS
PRESENTATIONS
STOCK INFORMATION
STOCK QUOTE & CHART
HISTORIC PRICE LOOKUP
INVESTMENT CALCULATOR
CORPORATE GOVERNANCE
DOCUMENTS & CHARTERS
BOARD OF DIRECTORS
MANAGEMENT
COMMITTEE COMPOSITION
FINANCIALS & FILINGS
SEC FILINGS
RESOURCES
INVESTOR FAQs
EMAIL ALERTS
IR INQUIRY
PIPELINE
AlloCAR T PRODUCT PIPELINE
THE ALPHA3 TRIAL
THE RESOLUTION TRIAL
DATABRIEF
EXPANDED ACCESS
SCIENCE
NEXT REVOLUTION IN CELL THERAPY
PLATFORM FOR TOMORROW
ON-DEMAND AVAILABILITY
SCIENTIFIC PUBLICATIONS
ABOUT US
AT A GLANCE
MANAGEMENT TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORS
PARTNERS
CORPORATE RESPONSIBILITY
NEWS CENTER
PRESS RELEASES
EVENTS
PERSPECTIVES
SOCIAL MEDIA
COMMUNITY GUIDELINES
INVESTORS
IR OVERVIEW
NEWS & EVENTS
PRESS RELEASES
EVENTS
PRESENTATIONS
STOCK INFORMATION
STOCK QUOTE & CHART
HISTORIC PRICE LOOKUP
INVESTMENT CALCULATOR
CORPORATE GOVERNANCE
DOCUMENTS & CHARTERS
BOARD OF DIRECTORS
MANAGEMENT
COMMITTEE COMPOSITION
FINANCIALS & FILINGS
SEC FILINGS
RESOURCES
INVESTOR FAQs
EMAIL ALERTS
IR INQUIRY
Search this website
SCHEDULE 13D/A: SCHEDULE 13D/A – Description
Allogene Therapeutics, Inc.
